Free U.S. shipping over $20015% off crypto paymentsSame-day shipping before 2pm CTLab-verified · COA with every lotFree U.S. shipping over $20015% off crypto paymentsSame-day shipping before 2pm CTLab-verified · COA with every lot
Comparison· 6 min read

BPC-157 vs TB-500: Which Healing Peptide Is Right for Your Research?

BPC-157 and TB-500 are the two most studied healing and tissue-repair peptides in the research community. They work through complementary but distinct mechanisms — which is why many researchers stack them rather than choose between them. This guide breaks down what each peptide does, how they differ, and when one is preferred over the other.

What is BPC-157?

BPC-157 (Body Protection Compound) is a 15-amino-acid synthetic peptide derived from a protective protein found in human gastric juice. Research has focused on its ability to accelerate repair of tendons, ligaments, muscle, gut lining, and even nerve tissue. It is typically administered subcutaneously near the injury site at 250–500 mcg, once or twice daily. Half-life is short (~4 hours), so frequent local dosing drives the effect.

What is TB-500?

TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring regenerative peptide. Where BPC-157 acts locally, TB-500 acts systemically — promoting cell migration, angiogenesis (new blood vessel formation), and broad tissue regeneration throughout the body. Research dosing is typically 2–5 mg per week, often split into two injections. Half-life is much longer (2–3 days).

Mechanism: localized repair vs systemic regeneration

BPC-157 upregulates VEGF and growth-hormone receptor expression at the injection site, making it a strong choice for a specific injured joint, tendon, or surgical site. TB-500 binds actin and recruits stem cells to damaged tissue across the entire body, which is why researchers use it for soft-tissue flexibility, hair regrowth signaling, and cardiovascular repair.

When researchers stack them

Because the mechanisms are complementary — local repair signaling plus systemic stem cell recruitment — the BPC-157 + TB-500 stack is one of the most common protocols in published peptide research. A typical research stack pairs 250 mcg BPC-157 twice daily with 2.5 mg TB-500 twice weekly during the acute recovery window, then tapers TB-500 to once weekly during maintenance.

Which one to choose

For a single localized injury (tendinopathy, post-surgical site, gut lining research), BPC-157 alone is often sufficient. For systemic injuries (multiple joints, full-body inflammation, cardiovascular research), TB-500 is more appropriate. For severe or complex recovery research, the stack outperforms either peptide alone in published animal models.

Peptides referenced in this guide

Frequently asked questions

Can you take BPC-157 and TB-500 together?+

Yes — they are routinely studied together because their mechanisms (local repair + systemic regeneration) do not overlap. The stack is a standard protocol in peptide research literature.

Which works faster, BPC-157 or TB-500?+

BPC-157 typically shows local effects within days because of frequent dosing near the injury site. TB-500's systemic effects build over 2–4 weeks due to its longer half-life and broader mechanism.

Is TB-500 stronger than BPC-157?+

Neither is 'stronger' — they target different problems. TB-500 is better for systemic, multi-site recovery. BPC-157 is better for a specific, localized injury.

More research guides